Duloxetine
Duloxetine Sandoz contains the active substance duloxetine. The medication increases the levels of serotonin and noradrenaline in the nervous system.
Duloxetine Sandoz is used in adults for the treatment of:
In most people with depression or anxiety, Duloxetine Sandoz starts working within two weeks of starting treatment, but improvement in mood may take 2 to 4 weeks. If after this time the patient does not feel better, they should tell their doctor. Even if there has been an improvement in the patient's condition, the doctor may recommend continued use of Duloxetine Sandoz to prevent a relapse of depression or anxiety.
In people with diabetic neuropathic pain, improvement may occur after several weeks. The doctor should be consulted if there is no improvement after 2 months.
cyproheptadine or enoxacin (medications used to treat certain infections).
The doctor should be told if the patient has high blood pressure or heart disease. The doctor will decide whether the patient should take Duloxetine Sandoz.
The following are reasons why taking Duloxetine Sandoz may not be suitable for the patient.
Before taking Duloxetine Sandoz, the doctor should be consulted if the patient:
Duloxetine Sandoz may cause restlessness or an inability to sit or stand still. If such symptoms occur, the doctor should be informed.
The doctor should also be contacted:
If the patient experiences objective and subjective symptoms such as restlessness, hallucinations, loss of coordination, rapid heartbeat, increased blood pressure, increased reflexes, diarrhea, coma, nausea, vomiting, as this may indicate serotonin syndrome.
In its most severe form, serotonin syndrome can resemble neuroleptic malignant syndrome.
Objective and subjective symptoms of neuroleptic malignant syndrome may include:
a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzyme activity (determined by blood tests).
Medications like Duloxetine Sandoz (so-called SNRIs) may cause sexual dysfunction (see section 4). In some cases, these symptoms persisted after treatment was stopped.
People with depression and/or anxiety disorders may sometimes have thoughts of self-harm or suicide. These thoughts may worsen at the start of treatment with antidepressant medications, as these medications start working only after some time, usually after 2 weeks, but sometimes later.
Suicidal thoughts, self-harm, or suicide attempts are more likely to occur:
It may be helpful to inform relatives or friends about the depression or anxiety disorder and ask them to read this leaflet. The patient may ask them to tell them if they notice that the depression or anxiety has worsened or if there are any worrying changes in behavior.
Duloxetine Sandoz should not normally be used in children and adolescents under 18 years of age. When taking medications from this group, patients under 18 years of age are at increased risk of side effects, such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and anger). However, the doctor may prescribe Duloxetine Sandoz to patients under 18 years of age, considering it to be in their best interest. If the doctor has prescribed Duloxetine Sandoz to a patient under 18 years of age and this has raised concerns, the doctor should be consulted. If such a patient taking Duloxetine Sandoz experiences or worsens the above symptoms, the doctor should be informed. Additionally, so far, there are no data on the long-term safety of using Duloxetine Sandoz in this age group regarding growth, maturation, and cognitive and behavioral development.
The doctor or pharmacist should be told about all medications the patient is currently taking or has recently taken, as well as any medications the patient plans to take.
Duloxetine, the active ingredient in Duloxetine Sandoz, is also contained in other medications used to treat:
Avoid taking more than one of these medications at the same time. If the patient is already taking other medications containing duloxetine, they should consult their doctor.
The doctor will decide whether Duloxetine Sandoz can be taken with other medications. Do not
start or stop taking other medications, including over-the-counter medications and herbal preparations, without consulting a doctor.
The doctor should also be told about taking any of the following medications:
If the patient is taking or has taken recently (within the last 14 days) another antidepressant medication called a monoamine oxidase inhibitor (MAOI), they should not take Duloxetine Sandoz. MAOIs include, for example, moclobemide (an antidepressant) and linezolid (an antibiotic). Taking MAOIs with many prescription medications, including Duloxetine Sandoz, can cause serious or life-threatening side effects. After stopping an MAOI, at least 14 days must pass before starting Duloxetine Sandoz, and after stopping Duloxetine Sandoz, at least 5 days must pass before starting an MAOI.
These include prescription medications such as benzodiazepines, strong painkillers, antipsychotic medications, phenobarbital, and antihistamines.
Tryptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, e.g., paroxetine and fluoxetine), selective norepinephrine reuptake inhibitors (SNRIs, e.g., venlafaxine), tricyclic antidepressants (e.g., clomipramine, amitriptyline), pethidine, buprenorphine, St. John's Wort (Hypericum perforatum), and MAOIs (e.g., moclobemide and linezolid). These medications increase the risk of side effects. If any unusual symptoms occur while taking any of these medications with Duloxetine Sandoz, the doctor should be contacted.
Medications that thin the blood or prevent blood clotting. They may increase the risk of bleeding.
Duloxetine Sandoz can be taken with or without food. Caution should be exercised when consuming alcohol while taking Duloxetine Sandoz.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medication.
The doctor should be told if the patient becomes pregnant or plans to become pregnant while taking Duloxetine Sandoz. Duloxetine Sandoz should only be taken after discussing the expected benefits and potential risks to the unborn child with the doctor.
The doctor and/or midwife should be informed about the use of Duloxetine Sandoz. Similar medications (SSRIs) taken during pregnancy may increase the risk of a serious condition in the baby called persistent pulmonary hypertension of the newborn (PPHN), which causes rapid breathing and bluish discoloration. These symptoms usually occur within the first 24 hours after birth. If the patient notices them in their baby, they should contact the midwife and/or doctor immediately.
If the patient takes Duloxetine Sandoz towards the end of pregnancy, the newborn may experience certain symptoms. They usually appear soon after birth or within a few days. These symptoms include: floppiness, trembling, seizures, difficulty feeding, difficulty breathing, and convulsions. If the newborn experiences any of these symptoms or the patient is concerned about their baby's health, they should contact the doctor or midwife, who will provide appropriate explanations.
If the patient takes Duloxetine Sandoz towards the end of pregnancy, there is an increased risk of excessive bleeding from the vagina shortly after delivery, especially if the patient has had bleeding disorders in the past. The doctor or midwife should be informed about the use of duloxetine so they can provide appropriate advice.
Available data on the use of duloxetine during the first three months of pregnancy do not generally indicate an increased risk of birth defects in the baby. If the patient takes Duloxetine Sandoz in the second half of pregnancy, there may be an increased risk of premature birth, especially between the 35th and 36th week of pregnancy (6 additional premature births per 100 women taking duloxetine in the second half of pregnancy).
The doctor should be told if the patient is breastfeeding. The use of Duloxetine Sandoz during breastfeeding is not recommended. The doctor or pharmacist should be consulted for advice.
Duloxetine Sandoz may cause drowsiness or dizziness. The patient should not drive or operate machinery until they know how Duloxetine Sandoz affects them.
This medication contains lactose. If the patient has intolerance to some sugars, they should consult their doctor before taking the medication.
This medication contains Allura Red AC (E 129), which may cause allergic reactions.
This medication contains less than 1 mmol (23 mg) of sodium per hard gastro-resistant capsule, which is considered "sodium-free".
Duloxetine Sandoz, 60 mg
This medication contains Orange Yellow FCF (E 110), which may cause allergic reactions.
This medication should always be taken as directed by the doctor or pharmacist. If there are any doubts, the doctor or pharmacist should be consulted.
The usual dose of Duloxetine Sandoz is 60 mg once a day, but the doctor will prescribe the dose suitable for each patient.
The usual starting dose of Duloxetine Sandoz is 30 mg once a day. In most patients, the dose is then increased to 60 mg once a day, but the doctor will prescribe the appropriate dose for each patient. The dose can be increased up to 120 mg, depending on the patient's response to treatment.
Duloxetine Sandoz is for oral use. The capsules should be swallowed whole with water.
Taking Duloxetine Sandoz at the same time every day may help remember to take it.
The doctor will inform the patient how long to take Duloxetine Sandoz. The patient should not stop taking the medication or change the dose without consulting the doctor. Proper treatment of the condition is essential for the patient to feel better. Without treatment, the patient's condition may persist or worsen and become difficult to treat.
If a larger dose than prescribed is taken, the doctor or pharmacist should be contacted immediately. Symptoms of overdose include: drowsiness, coma, serotonin syndrome (a rare reaction that can cause excessive happiness, drowsiness, coordination disorders, restlessness, especially motor, feeling of intoxication, fever, sweating, or muscle stiffness), seizures, vomiting, and rapid heartbeat.
If a dose is missed, it should be taken as soon as remembered. However, if the time for the next dose is near, the missed dose should be skipped and a single dose taken as usual. A double dose should not be taken to make up for the missed dose.
A higher daily dose of Duloxetine Sandoz than prescribed by the doctor should not be taken.
The capsules should not be stopped without the doctor's advice, even if the patient feels better. If the doctor decides that the patient no longer needs to take Duloxetine Sandoz, they will recommend gradually reducing the dose over at least 2 weeks before completely stopping the medication.
In some patients who stop taking Duloxetine Sandoz abruptly, the following symptoms may occur:
These symptoms are usually not severe and resolve within a few days. However, if they are bothersome, the doctor should be consulted.
If there are any further doubts about taking this medication, the doctor or pharmacist should be consulted.
Like all medications, Duloxetine Sandoz can cause side effects, although not everybody gets them.
These effects are usually mild or moderate and often disappear within a few weeks.
In children and adolescents under 18 years of age with depression taking duloxetine, weight loss was observed at the start of treatment. After 6 months of treatment, body weight increased and normalized with that of other children and adolescents of the same age and sex.
Duloxetine Sandoz may cause effects that the patient may not be aware of, such as increased liver enzyme activity or:
If any side effects occur, including those not listed in this leaflet, the doctor, pharmacist, or nurse should be told.
Side effects can be reported directly to the Department of Adverse Reaction Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301/fax: +48 22 49 21 309/website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of this medication.
The medication should be stored out of sight and reach of children.
Do not use this medication after the expiry date stated on the blister and carton after EXP.
The expiry date refers to the last day of the month stated.
Do not store above 30°C.
Medications should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medications that are no longer needed. This will help protect the environment.
Duloxetine Sandoz, 30 mg
A capsule (size 2) with a matte white body and "30" printed on it and a matte dark blue cap, containing 4 white or off-white, round, biconvex tablets.
Duloxetine Sandoz, 60 mg
A capsule (size 0E) with a yellow-green body and "60" printed on it and a matte dark blue cap, containing 8 white or off-white, round, biconvex tablets.
Hard gastro-resistant capsules are packaged in PVC/PE/PCTFE/Aluminum or PA/Aluminum/PVC/Aluminum blisters and placed in a cardboard box.
Package sizes: 7, 14, 28, 30, 50, 56, 84, 98 hard gastro-resistant capsules
Not all package sizes may be marketed.
Sandoz GmbH
Biochemiestrasse 10
6250 Kundl, Austria
Pharmathen International S.A.
Industrial Park Sapes Rodopi Prefecture, Block No 5
69300 Rodopi, Greece
Pharmathen S.A.
Dervenakion 6
15351 Pallini Attiki, Greece
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben, Germany
Sandoz Polska Sp. z o.o.
ul. Domaniewska 50 C
02-672 Warsaw
tel. 22 209 70 00
Date of Last Revision of the Leaflet:08/2024
Sandoz Logo
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.